Live Breaking News & Updates on Brigitte Keller|Page 1

Stay updated with breaking news from Brigitte keller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-News: Apogenix AG: Apogenix' new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model

EQS-News: Apogenix AG / Key word(s): Scientific publication Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Apogenix’ new CD40 agonist. ....

United Kingdom , Baden Wüberg , Tim Illidge , Brigitte Keller , Judith Teumer , Katja Arnold , Thomas Hoeger , Mc Services , European Medicines Agency , Distribution Services , University Of Manchester , Professor Tim Illidge , Tumor Necrosis Factor Receptor Superfamily , Superfamily Agonists , Corporate News , Regulatory Announcements , Eqs News , Era Cd40l , Et Cest ,

EQS-News: Apogenix AG: Apogenix' Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept Plus Standard of Care in Newly Diagnosed Glioblastoma Multiforme

EQS-News: Apogenix AG / Key word(s): Study/Study results Apogenix' Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept ....

Hong Kong , Wei Kuo Chen , Macau General , United States , Chang Gung Memorial Hospital , Taoyuan Xian , Baden Wüberg , Katja Arnold , Hsiu Chi Chen , Chia Hua Chen , Chia Wen Huang , Hong Chieh Tsai , Linkou Chang Gung , James Xue , Brigitte Keller , Kuo Chen Wei , Iyu Lin , Judith Teumer , Ian Yi Feng Chang , Ya Jui Lin , Gerry Cox , Ting Chen , Thomas Hoeger , Canbridge Pharmaceuticals , Canbridge Life Sciences , Canbridge Pharmaceuticals Inc ,

EQS-News: VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG

EQS-News: Vakzine Projekt Management GmbH / Key word(s): Study results VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG 25.01.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. VPM ov. ....

Brigitte Keller , Greg Plunkett , Leander Grode , Karsten Fischer , Mc Services , Contract Research Organisation , Distribution Services , Vakzine Projekt Management Gmbh , Memo Therapeutics , Investigational New Drug Application , Chief Executive Officer , Managing Director , Projekt Management Gmbh , Corporate News , Regulatory Announcements , Et Cest ,

EQS-News: Vakzine Projekt Management GmbH: VPM oversees clinical trial and translational project management - Positive Phase I data of client Memo Therapeutics AG

EQS-News: Vakzine Projekt Management GmbH / Key word(s): Study results VPM oversees clinical trial and translational project management - Positive Phase I data of client Memo Therapeutics ....

Brigitte Keller , Kostenloser Wertpapierhandel , Greg Plunkett , Leander Grode , Karsten Fischer , Mc Services , Contract Research Organisation , Distribution Services , Vakzine Projekt Management Gmbh , Memo Therapeutics , Projekt Management Gmbh , Investigational New Drug Application , Chief Executive Officer , Managing Director , Corporate News , Regulatory Announcements ,

EQS-News: HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor

EQS-News: HepaRegeniX GmbH / Key word(s): Personnel HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor 23.11.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor Tübingen (Germany), November 2. ....

Baden Wüberg , United Kingdom , Bernard Katz , Max Delbr , Katja Arnold , Lars Zender , Shaun Brown , Andreas Busch , Wolfgang Albrecht , Brigitte Keller , Ascenion Gmb , Bayer Pharma , Johann Wolfgang Goethe , Mc Services , University Hospital Tubingen , University In Frankfurt , Global Head Of Cardiovascular Research At Hoechst , Boehringer Ingelheim Venture Fund , German Cancer Research Center , Distribution Services , Shire Plc , Cyclerion Therapeutics Inc , Max Planck Institute Of Molecular Genetics , Novo Holdings , Heparegenix Gmbh , Senior Advisor ,